May 13, 2022 – COVID-19
Please review for important guidance related to reporting protocol deviation/violations to the IRB related to the global Omnipaque shortage
DF/HCC has one of the largest clinical research initiatives in the country, taking a unified approach to approving, activating, monitoring, and supporting the cancer-related clinical trials conducted at our member institutions. For more information, please take a moment to review the functions of each of the 3 distinct clinical research offices below, and continue on to the appropriate destination.
For your convenience there are many ways to find the Policies, Guidance, Forms, Templates, and Resources that you may be looking for. Expand the 'CRS Introduction' section for a walkthrough, or head to one of DF/HCC's three clinical research offices below.
May 13, 2022 – COVID-19
Please review for important guidance related to reporting protocol deviation/violations to the IRB related to the global Omnipaque shortage
January 05, 2022 – COVID-19
Please read for updated policy exception and guidance related to the recent staffing shortages and COVID-19 case surge
View resources that may be helpful within the Clinical Research Support section of the DF/HCC website.
New to clinical research at DF/HCC, or need a refresher on where to find certain resources? View the New PI and Staff page for more information or for support.
Search all documents via the Document Library search engine or look up a document relating to the protocol lifecycle stage (creation, activation, close-out, etc.) that it pertains to.
View a complete list of contact information for each Clinical Research Office at DF/HCC.
Clinical Research at Dana-Farber/Harvard Cancer Center member institutions is facilitated by way of a unified clinical research effort across all member institutions. There are three offices responsible for coordinating this unified effort: The Research Informatics Operations (RIO), The Office of Data Quality (ODQ), and The Office for Human Research Studies (OHRS).
Although all documents are available in a centralized place via the Protocol Lifecycle, or the Document Library, support for specific clinical research areas, functions, or software used across the Cancer Center can be attained by visiting the corresponding office page. View the common functions for each office below.

Quickly discover how to conduct research within DF/HCC including writing and activating protocols.
September 01, 2025 – Office for Human Research Studies
Review important DF/HCC policy updates related to IND safety reporting, as well as a recording of the July 29, 2025 Office Hours session for more information.
March 17, 2025 – Office for Human Research Studies
Review changes to the DFCI IRB SAE & INDSR Reporting Policy and a reminder regarding ICF version control. View a recording of the March 12th, 2025 Office Hours session for more information.
January 31, 2025 – Office for Human Research Studies
Review updated DF/HCC and DFCI IRB consent policies and documents. View recordings of the Dec 16th, 2024 and Jan 16th, 2025 Office Hours sessions for more information.